| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $40,959,000 ) (Continued on the next page) |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA241194 | Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs | 000 | 5 | NIH | 1/8/2024 | $345,871 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MD014726 | APOL1 Nephropathy: Linking Genetics and Mechanisms | 000 | 5 | NIH | 12/5/2023 | $430,416 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK123400 | Novel signaling pathways in the ciliary inversin compartment | 000 | 5 | NIH | 12/7/2023 | $164,484 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA240257 | Role of KAT5 in lung cancer | 001 | 5 | NIH | 4/17/2024 | $19,957 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA240257 | Role of KAT5 in lung cancer | 000 | 5 | NIH | 1/24/2024 | $359,239 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI148161 | T cells in Lupus | 000 | 5 | NIH | 11/13/2023 | $393,750 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 000 | 5 | NIH | 11/15/2023 | $753,367 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23ES035863 | Climate Variability and Respiratory Health in Asthma and COPD | 000 | 1 | NIH | 3/27/2024 | $256,202 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 001 | 1 | AHRQ | 1/10/2024 | $999,286 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 001 | 1 | AHRQ | 1/10/2024 | -$999,286 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 000 | 1 | AHRQ | 12/27/2023 | $999,286 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 000 | 1 | NIH | 12/27/2023 | $709,923 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK135672 | Cav1.2 in bladder physiology and pathology | 000 | 1 | NIH | 3/21/2024 | $580,586 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133226 | Central vs. Peripheral Mechanisms of Headache: Cortex, Thalamus, Dorsal Horn | 000 | 1 | NIH | 4/4/2024 | $419,283 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK139288 | Mitochondrial DAMPs-driven Mechanisms of Liver Fibrosis in NASH | 000 | 1 | NIH | 3/5/2024 | $653,226 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171121 | Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | 000 | 1 | NIH | 12/12/2023 | $643,002 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082016 | Wake-sleep Circuitry in Neurodegenerative Dementias | 000 | 1 | NIH | 11/16/2023 | $900,121 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00EY032181 | Epigenomic mechanisms regulating RGC survival and axon regeneration | 000 | 4 | NIH | 1/26/2024 | $249,998 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK136699 | Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration | 000 | 1 | NIH | 4/19/2024 | $774,435 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK139434 | Targeted mRNA Delivery to Improve Diabetic Wound Healing | 000 | 1 | NIH | 2/21/2024 | $152,236 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133187 | Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease | 000 | 1 | NIH | 3/12/2024 | $665,971 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32ES036026 | Air pollution, biomarkers of exposure, and lung function in vulnerable populations | 000 | 1 | NIH | 2/9/2024 | $86,004 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171101 | Rechargeable Anti-thrombogenic Films for Blood Contacting Applications | 000 | 1 | NIH | 12/8/2023 | $688,880 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL171855 | Mixed meal tolerance test elicited metabolite responses as novel markers of cardiometabolic risk | 000 | 1 | NIH | 2/15/2024 | $190,705 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI176120 | Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards | 000 | 1 | NIH | 12/1/2023 | $194,513 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK138503 | Integrating signals that control APOL1 gene expression and drive kidney disease | 000 | 11 | NIH | 1/19/2024 | $540,299 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 001 | 4 | NIH | 4/16/2024 | $24,899 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 000 | 4 | NIH | 2/23/2024 | $224,101 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer?s disease | 000 | 2 | NIH | 2/2/2024 | $736,634 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH131586 | FastPlex: A Fast Deep Learning Segmentation Method for Accurate Choroid Plexus Morphometry | 000 | 2 | NIH | 3/28/2024 | $560,472 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082093 | Non-coding RNAs in resilience to Alzheimer?s Disease | 001 | 2 | NIH | 2/26/2024 | $759,851 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA271601 | Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments. | 001 | 2 | NIH | 4/17/2024 | $32,569 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA271601 | Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments. | 000 | 2 | NIH | 3/26/2024 | $586,256 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01HL161034 | Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans | 000 | 2 | NIH | 1/29/2024 | $160,270 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS126282 | Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain Injury | 001 | 2 | NIH | 4/10/2024 | $52,273 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS126282 | Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain Injury | 000 | 2 | NIH | 12/18/2023 | $672,101 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99HL166778 | Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation | 000 | 2 | NIH | 4/16/2024 | $164,484 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL164976 | Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes | 000 | 2 | NIH | 2/15/2024 | $191,186 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R03NS128993 | The Role of Neurotensin-Expressing Neurons of the Extended Ventrolateral Preoptic Nucleus in REM Sleep Regulation | 000 | 2 | NIH | 1/16/2024 | $86,450 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99DK134853 | Competing effects of AgRP and POMC neurons on cAMP signaling in downstream neurons in vivo | 000 | 2 | NIH | 1/24/2024 | $90,000 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32DK135247 | Functional mapping of the parabrachial nucleus: from gastrointestinal topography to satiety | 000 | 2 | NIH | 11/3/2023 | $71,792 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079864 | Brain Vulnerability in Delirium and Alzheimer?s Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation | 000 | 2 | NIH | 11/15/2023 | $735,517 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 001 | 2 | NIH | 4/17/2024 | $35,580 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 000 | 2 | NIH | 12/22/2023 | $640,414 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01CA263986 | Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients | 003 | 3 | NIH | 4/17/2024 | $20,244 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01CA263986 | Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients | 002 | 3 | NIH | 12/11/2023 | $344,507 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK134806 | Investigating the regulation of distinct human adipocyte subpopulations | 000 | 2 | NIH | 11/2/2023 | $150,736 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21MH133001 | Identification of Distinct Biotypes in Clinical High Risk for Psychosis State Using Objective Brain-Based Biomarkers | 000 | 2 | NIH | 1/12/2024 | $139,687 |
| | 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AR080203 | Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea | 001 | 2 | NIH | 4/11/2024 | -$169,883 |
|
